Health & Medicine

WASHINGTON, July 16 — The Association for Diagnostics & Laboratory Medicine, the global scientific and medical professional organization formerly known as the…

NEW YORK, July 16 — For the millions of families touched by Alzheimer’s disease, the science can feel impossibly distant. But behind…

BLOOMINGTON, July 15 — Researchers at the Indiana University School of Medicine have published a study that cuts through the usual clinical…

INDIANAPOLIS, July 15 — A study published yesterday by researchers at the Indiana University School of Medicine is bringing new urgency to…

INDIANAPOLIS, July 15 — The shift in bowel cancer treatment is no longer just about detecting it early. A new study from…

NEW YORK, July 15 — A new study is giving families and doctors a clearer, sharper picture of the long-term risks tied…

WASHINGTON, July 15 — A new case-control study, the largest of its kind ever conducted in the United States, has delivered a…

SAN FRANCISCO, July 15 — Ernexa Therapeutics, a biotechnology company operating in the U.S. healthcare sector, is preparing to advance its lead…

NEW YORK, July 15 — A new targeted cancer therapy platform is moving toward its first human trials, offering a potential advance…

NEW YORK, July 15 — Ernexa Therapeutics is moving its lead candidate ERNA-101 toward a first-in-human Phase 1 study, with the trial…

WASHINGTON, July 15 — A senior epidemiologist at a major U.S. university or government agency is the lead researcher behind a new…

INDIANAPOLIS, July 15 — A new study from the Indiana University School of Medicine has shed light on a critical window of…

INDIANAPOLIS, July 15 — A study released yesterday by the Indiana University School of Medicine documents a stark divide in bowel cancer…

SINGAPORE, July 15 — A new cancer therapy candidate is taking its first step from the laboratory bench toward the bedside, with…

WASHINGTON — A new study linking heavy marijuana smoking to potential health risks is prompting public health officials to consider updated warnings,…

WASHINGTON, July 15 — A major new study, described as the largest of its kind in the United States, has found that…

BEIJING, July 15 — Akeso’s experimental cancer drug cadonilimab is now being studied in a Phase II clinical trial in the United…

ISLAMABAD, July 15 — Akeso, the Chinese biopharmaceutical company, has advanced its investigational drug cadonilimab into a Phase II clinical trial in…

WASHINGTON, July 15 — V. Craig Jordan, the British-American pharmacologist whose work turned tamoxifen into a cornerstone of hormone-positive breast cancer therapy,…

ISLAMABAD, July 15 — For millions of women worldwide, tamoxifen has been a cornerstone of breast cancer treatment and prevention for decades.…

MANILA, July 15 — For women across the Philippines and the wider region facing hormone receptor-positive breast cancer, a medication called tamoxifen…